0202, Volume 8, Issue 2, Pages: 610-620  
J. Environ. Treat. Tech.  
ISSN: 2309-1185  
Journal web link: http://www.jett.dormaj.com  
Antiviral Pneumonia to Treat Influenza Virus  
1
,2  
3,1  
1,2  
Sargol Mazraedoost *, Seyyed Mojtaba Mousavi , Seyyed Alireza Hashemi , Ahmad  
Gholami4  
1
Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 71348-14336  
2
Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran  
3
Department of Chemical Engineering, National Taiwan University of Science and Technology, Taiwan  
4
Pharmaceutical Sciences Research Center and Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical  
Sciences, Shiraz, Iran  
Received: 03/02/2020  
Accepted: 13/03/2020  
Published: 20/05/2020  
Abstract  
Influenza, an infectious disease of the respiratory system, represents a tremendous sized burden for public health. Influenza was once  
found not through a direct learn about the disorder in humans, but as a substitute from research on animal diseases. An ailment that can  
resemble the frequent cold, influenza packs a powerful and on occasion deadly punch. As numerous as half-a-million people around the  
world die yearly from flu. The perpetrator is a virus that mutates to steer clear of our immune systems, leaving vaccines and remedies  
scrambling to preserve up. In many years, a mutation creates a pathogen that is specifically nasty, ensuing in pandemic flu. Influenza is  
an acute respiratory disorder brought on by using the influenza A or B virus. It often happens in outbreaks and epidemics worldwide,  
frequently in the course of the iciness season. Significant numbers of influenza virus particles exist in the respiratory secretions of  
infected persons so that infection can be transmitted via sneezing and coughing using large-particle droplets. The imply duration of  
influenza virus shedding in immunocompetent adult patients is around 5 days but may also proceed for up to 10 days or further mostly  
in children, elderly adults, patients with chronic illnesses, and immunocompromised hosts. Influenza generally starts with the abrupt  
onset of high-grade fever, myalgia, headache, and malaise. These manifestations are attended by way of signs of respiratory tract ailments  
such as non-productive cough, sore throat, and nasal discharge. After an ordinary course, influenza can affect different organs such as  
the lungs, brain, and heart more than it can affect the respiratory tract and motive hospitalization. The excellent way to stop influenza is  
to administer annual vaccinations. For centuries, new strains of influenza have emerged to produce human pandemics, inflicting massive  
illness, death, and disruption. There have been four flu pandemics within the earlier hundred a long time. Throughout this time,  
globalization processes, globalisation processes, alongside advances in medicine and epidemiology, have altered the way these  
pandemics are experienced.  
Keywords: Pandemic; Influenza; Human; Infectious disease  
Introduction1  
Influenza is a transmittable viral illness that influences the  
harvest time and snowy climate in mild zones and influence a  
massive factor of grown-ups and youngsters, anyway seasons  
in an alternate way sway age associations and seriousness (Fig  
1
apex respiratory tract, which envelops the upper and point of  
respiratory confinement sections. It is accelerated by methods  
for utilizing an enormous range of Influenza infections. A  
portion of these infections can infect people, and some are  
specific to notable species. These infections are transmissible  
through respiratory beads ousted from the mouth and  
respiratory machine all through hacking, talking, and sniffling.  
The influenza disease can be transmitted by the ability to  
contact lifeless things dirtied with the infection and contacting  
the nostril or eye. Influenza can be transmitted heretofore than  
the influenced individual is symptomatic and till 5 to 7 days  
after disease. After disease, it takes a couple of days for the  
majority of the empowering unfortunate casualties to show  
signs of improvement. Ultimately, on the other hand,  
inconveniences that comprise of pneumonia and death toll are  
visited in positive high-chance gatherings. These associations  
incorporate more youthful kids, old, immunocompromised, and  
pregnant females. Indications of flu comprise of a runny nose,  
high fever, hack, and sore throat. Flu spreads and effectively in  
occasional pandemics. Influenza scourges occur every single  
1
) (1-4).  
2 Etiology  
Influenza viruses belong to the household of viruses termed  
“Orthomyxoviridae,” an RNA kind virus with various antigenic  
characteristics. They are divided into three most important  
types: A, B, and C (Fig 2). Furthermost of the epidemics and  
outbreaks of influenza are induced by types A and B, with type  
C being commonly accountable for sporadic moderate-higher  
respiratory symptoms (5, 6). Infections have round or  
filamentous shapes with an envelope, containing glycoproteins  
and a single-stranded RNA quality. The 2 most extraordinary  
fundamental glycoproteins over the outer layer of this season's  
flu virus disease are hemagglutinin (H, or HA) and  
neuraminidase (N, or NA). The two include quintessential parts  
inside the pathogenesis of the sickness. For flu kind A, at  
slightest sixteen in specific variable hemagglutinins (H1 to  
H16) and 9 unimaginable NAs (N1 to N9) have been analyzed  
so distant.  
Corresponding author: Seyyed Alireza Hashemi, (a) Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences,  
Shiraz, Iran. 71348-14336. (b) Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz  
University of Medical Sciences, Shiraz, Iran.  
0
16  
Journal of Environmental Treatment Techniques  
0202, Volume 8, Issue 2, Pages: 610-620  
Fig 1. Structure of the influenza virus. 3D illustration displaying floor glycoprotein spikes hemagglutinin blue and neuraminidase green, M2 protein  
red, capsid made of M1 protein pink and eight fragments of RNA  
Fig 2. Influenza virus type  
With the valuable asset of this one of a shape antigen, the flu  
sort A infection is mainly subdivided into subtypes based on  
total variable designs of their impressive H or N proteins (e.g.,  
H1N1 or H3N2). By the by, within the terminology of the  
infections, other factors for illustration the locale of preparatory  
confinement and the yr of segregation are covered (7-10). The  
influenza B virus has a related viral form to form A; however,  
due to the constant antigenic characters of HA and NA, there  
are no subtypes in this virus. Still, some small antigenic  
variabilities have been stated on account that 1970 in this virus,  
with the virus, had started out to diverge into 2 antigenically  
awesome lineages (11).  
3
Epidemiology  
Researchers isolated Influenza A in 1933, seven years later,  
they remoted influenza B. Influenza viruses in specific  
geographic areas of the northern and southern hemispheres are  
recognized as an influenza epidemic which takes place every yr  
at some stage in the winter seasons.  
0
11  
Journal of Environmental Treatment Techniques  
0202, Volume 8, Issue 2, Pages: 610-620  
Fig 3. Summary of the ecology of influenza viruses (12)  
The severity, size of influenza, and age organizations that  
are profoundly impacted and complication expenses such as  
hospitalizations and deaths range substantially all via one of a  
kind influenza seasons. When H3N2 viruses predominate, the  
season tends to be extra extreme, particularly amongst youth  
and the elderly. World Health Organization (WHO) conducts  
world influenza virologic surveillance that shows influenza  
viruses are isolated each month from human beings in a  
geographic region. In temperate regions, influenza endeavour  
peaks for the duration of the wintry weather months.  
automatically in hospitals involve further re-evaluation.  
Furthermore, contact with contaminated surfaces containing  
respiratory droplets is some other practicable supply of ailment  
transmission. In adults barring other underlying diseases, the  
shedding of the virus begins from 24 to forty-eight hours earlier  
than disorder manifestation, and the shedding stops after 6 or 7  
days according to most research and after 10 days in accordance  
with some other investigations (18). It is viewed that longer  
intervals of shedding and infectiousness can occur in children,  
elderly adults, immunocompromised hosts, and patients with  
chronic illnesses (Fig 3) (12, 19).  
4
Transmission  
In the respiratory secretion of the sufferers struggling from  
5
Complications of Influenza  
influenza, massive amounts of virus load are often present, and,  
as a result, each contaminated man or woman can be  
transmitting contamination to other folks by sneezing and  
coughing. It has been posited that the disorder is transmitted  
notably through large-particle droplets (>5 µ).(13) Owing to the  
large dimension of infectious droplets, shut contact is wished  
for the acquisition of the disease. These large particles usually  
do not continue to be suspended in the air for a lengthy time,  
and they tour only quick distances. Airborne transmission is,  
therefore, now not often regarded for disorder unfold (14, 15).  
Though confined data exhibit that small particle respiratory  
droplets, which emerge as aerosolized and can stay deferred in  
the air for a long time, also contain the influenza virus and can  
potentially cause disease to unfold (16). In the latest study,  
aerosol transmission accounted for around half of all the  
transmission events. This suggests that activities to minimize  
transmission with the aid of contact or large droplets may  
additionally not be sufficient to manage the transmission of the  
influenza A virus in households or communities (17).  
Consequently, the prevention techniques that are drawn  
5
.1 Pneumonia  
The most critical and frequent complication of influenza is  
pneumonia, now not least in high-risk individuals. Pneumonia  
may also appear as a continuum of the acute influenza  
syndrome when induced using the influenza virus (primary  
pneumonia) or as a blended viral and bacterial contamination  
after a hole of a few days (secondary pneumonia).  
5
.2 Primary Influenza Viral Pneumonia  
The illness happens after the regular route of influenza with  
the quick development of fever, dyspnea, cough, cyanosis, and  
challenging breathing. It takes place predominantly amongst  
individuals with cardiovascular or underlying pulmonary  
ailments such as asthma. Physical examination is in pick out of  
bilateral lung involvement, and imaging findings in the lungs  
represent reticular or reticulonodular opacities with or barring  
superimposed consolidation. Sometimes the radiological look  
of primary influenza pneumonia can be challenging to  
distinguish from pulmonary edema due to the truth of the  
presence of perihilar congestion and hazy opacification, at least  
0
1ꢀ  
Journal of Environmental Treatment Techniques  
0202, Volume 8, Issue 2, Pages: 610-620  
in the minimize lobes. Less commonly, radiographs  
demonstration focal zones of infiltration (20-22).  
attempted and the patients, reaching out from 4.4% to 80% in  
contrast with cell culture as the best quality level test.  
Commonly used pneumonia severity evaluation equipment  
such as the CURB65 or the Pneumonia Severity Index are not  
beneficial in finding out which patients to hospitalize due to  
primary influenza pneumonia, considering that these tools have  
now not been developed and validated at some point of an  
influenza pandemic (23). Therefore, the sickness occurs after  
the ordinary course of influenza with the quick development of  
fever, dyspnea, cough, cyanosis, and severe breathing. It takes  
place predominantly amongst humans with cardiovascular or  
underlying pulmonary illnesses such as asthma. Physical  
examination is in pick out of bilateral lung involvement, and  
imaging findings in the lungs signify reticular or  
reticulonodular opacities with or except superimposed  
consolidation. Sometimes the radiological seems to be of  
fundamental influenza pneumonia can be challenging to  
distinguish from pulmonary edema due to the truth of the  
presence of perihilar congestion and hazy opacification, at least  
in the reduce lobes. Less frequently, radiographs demonstrate  
focal areas of infiltration (24). The most severe instances grow  
swiftly to acute respiratory misery syndrome and multilobar  
alveolar infiltrations. These patients are ordinarily current with  
new dyspnea and extreme hypoxemia 2 to 5 days after the onset  
of common influenza symptoms. Hypoxemia will increase  
swiftly and causes respiratory failure, requiring intubation and  
mechanical ventilation, possibly after solely one day of  
hospitalization (25, 26).  
3
Diagnosis  
Their clinical appearances analyze the lion's share of  
influenza cases, and there is no requirement for research facility  
tests. Be that because it may, in uncommon circumstances, the  
conclusion of influenza requires research facility affirmation  
utilizing available tests such as corrosive nucleic tests (e.g.,  
polymerase chain response [PCR]) or quick determination units  
or once in a while infection segregation by culture strategies.  
3
.1 Rapid Diagnosis Influenza Tests  
Quick influenza symptomatic tests distinguish flu viral  
antigens and screen patients with suspected influenza  
conveniently in comparison to other demonstrative modalities.  
The first broadly utilized method is based on the detection of  
viral antigens within the respiratory emissions of patients by  
immunologic strategies. All quick tests are performed with ease  
and can give comes about inside 30 minutes. Each test changes  
concerning whether it can recognize between influenza A and  
B. In any case, these tests have hence distant been incapable of  
indicating sorts of flu A, such as H1N1 and H3N2. Then when  
all is said in done, specificities achieved by these tests are tall  
and practically identical between the makers. In any case, their  
sensitivities have seemed magnificent heterogeneity over  
considers relying upon the idea of the tests attempted and the  
patients, reaching out from 4.4% to 80% in contrast with cell  
culture as the best quality level test (33-35). As a familiar  
concept, affectability in grown-ups is less than that detailed in  
more youthful patients.  
Furthermore, the affectability may be higher at the onset of  
the malady, when the next stack of the infection exists.  
Financial thinks about comparing fast testing to the clinical  
determination of influenza stay uncertain. Without a doubt, a  
few considers have proposed that, in most cases, clinical  
judgment combined with antiviral treatment is the foremost  
cost-effective procedure (36), whereas unused ponders have  
proposed that testing may be the foremost cost-effective  
methodology and appeared that oseltamivir treatment based on  
the point-of-care (POC) test could be a prevailing alternative  
compared to customary approaches without screening tests  
within the pattern situation which they can be cost-effective in  
2
.3 Secondary Bacterial Pneumonia  
The occurrence of secondary bacterial pneumonia extended  
from 2% to 18% throughout the influenza pandemic in 1957–  
8 (27). A threefold amplify in the incidence of secondary  
5
Staphylococcus aureus pneumonia during the influenza  
pandemic of 19689 compared to a non-epidemic length of  
pneumonia etiologies was determined (28).  
As of late, community-acquired methicillin-resistant  
Staphylococcus aureus was decided after regular influenza  
(29); in any case, another widespread etiologic bacterium is  
Streptococcus pneumonia. The influenced character  
encompasses a first influenza disease, went with through  
potential of an enhancement length enduring maximally 2  
weeks. The rehash of the side impacts, for illustration, fever,  
useful hack, and dyspnea and disclosures of unused unions in  
chest imaging, can be found in included patients.  
8
0% of cases concurring to the cost-effectiveness worthiness  
bend. Besides, influenza antiviral treatment based on POC may  
well be cost-effective in particular conditions of execution,  
cost, and infection predominance (37).  
2
.4 Non-Pulmonary Complications  
Regardless of its respiratory impacts, the disease can apply  
results for unmistakable body structures, for the case, the  
musculoskeletal, cardiovascular, and neurologic systems.  
Myocarditis and pericarditis speak to abnormal at that point  
once more critical issues of regular or widespread influenza. In  
a planned consider, half of grown-up flu sufferers but cardiac  
complaints had beat score ECG discoveries at introduction  
3
.2 Molecular Tests  
Due to the restriction in other demonstrative modalities in  
influenza location, atomic tests have progressively been  
considered the gold standard symptomatic strategy for the  
location of the influenza disease in healing center based  
demonstrative research facilities. Even though  
a few  
(30). Myocarditis, for the most part, settles by 28 days, and the  
enhancement strategies have been created, the more significant  
part of the current assaysparticularly those utilized in clinical  
laboratoriesis based on the PCR enhancement strategy. These  
tests can check a few targets concurrently and subsequently  
give sort and subtype data for each infection. Furthermore, they  
can be adjusted quickly for the location of novel targets; these  
highlights (38) played a primary part amid the influenza  
widespread of 2009. PCR is possibly more delicate than cell  
culture, and it can distinguish the nonviable infection in tests.  
The affectability of these tests is subordinate to the test location  
of the understanding and is comparable to that of the fast tests.  
Swab tests of a nasopharyngeal beginning can get higher  
affectability.  
patients include great heart-muscle work without  
a
a
diminished launch division. Noteworthy myositis and  
rhabdomyolysis have seldom been detailed with regular flu  
(31), but diverse sums of creatine phosphokinase rise have been  
detailed in numerous considers after conventional or  
widespread flues (32, 33). Mellow myositis and myoglobinuria  
with delicate leg or back muscles can primarily be seen in  
children, the when all is said in done specificities achieved by  
these tests are tall and practically identical between the makers.  
In any case, their sensitivities have seemed magnificent  
heterogeneity over considers relying upon the idea of the tests  
0
1ꢁ  
Journal of Environmental Treatment Techniques  
0202, Volume 8, Issue 2, Pages: 610-620  
Diagnostic Tests  
Fig 4. Diagnostic Tests  
PCR-based atomic measures have yielded fabulous clinical  
utility for the discovery and distinguishing proof of influenza  
disease at the bedside as POC, and various Nourishment and  
Sedate Organization (FDA)-cleared commercial gadgets are  
presently accessible (39-41).  
6
Pathophysiology  
Influenza is an acute infection that points to the upper  
respiratory tract and thought processes disease of the upper  
respiratory tree and trachea. The great signs endure for seven to  
ten days, and the sickness is self-limited in most solid people.  
The resistant reaction to the viral disease and the intergalactic  
reaction is dependable for the viral disorder that incorporates  
over the top fever, coryza, and physical make-up hurts. High-  
risk companies who have nonstop lung illnesses, cardiac  
illness, and being pregnant are higher slanted to extraordinary  
inconveniences such as imperative viral pneumonia, auxiliary  
bacterial pneumonia, hemorrhagic bronchitis, and passing.  
These extraordinary inconveniences can upgrade in as small as  
forty-eight hours from the beginning of indications. The  
infection duplicates within the more prominent and diminishes  
respiratory sections starting from the time of immunization and  
cresting after forty-eight hours, on average.  
4
Part of the Research facility Conclusion of Flu  
in Clinical Case Administration  
Given the self-limiting nature of the infection in something  
else reliable people, there is no requirement for demonstrative  
tests in all showing cases. Demonstrative tests ought to be  
conducted in case the comes about of the test is thought to be  
able to impact consequent clinical administration, and in case  
the comes about of the test are regarded persuasive in choices  
on the start of particular antiviral treatment, effect on other  
symptomatic tests, anti-microbial treatment decision-making,  
and contamination control practices (42, 43). Moreover, amid  
influenza seasons, hospitalized people of any age with fever and  
7
Viral entry: How does the virion enter the  
extreme respiratory symptomsincluding those with  
a
conclusion of community-acquired pneumonianeed research  
facility testing independent of time from ailment onset.  
host?  
The excellent way in which influenza is transmitted is from  
individual to individual by mist concentrates and beads.  
Influenza at that point enters the have through the respiratory  
tract. In a human lung, there are almost 300 million terminal  
sacs, called alveoli, that work in vaporous trade between  
motivated discussion and the bloodthe entire absorptive  
region of the human lung ranges from 80-120 m2. The resting  
ventilation rate in people is around 6 liters of discussing per  
miniature, which presents enormous numbers of outside  
particles and aerosolized beads, possibly containing infection  
into the lungs. Testimony of outside particles depends on their  
estimate: inward breath of tiny particles does not result in  
assimilation through the alveoli or bronchial framework. Little  
beads with a breadth of approximately 1 to 4 µm accelerate  
within the little aviation routes. Much bigger particles are either  
not able to enter the respiratory contraption or are kept within  
the best respiratory tract (Figure 5A).Various have defense  
components comprising of mechanical deterrents piece  
respiratory tract disease. The respiratory tract is included with  
a mucociliary layer comprising of ciliated cells, mucus-  
secreting cells, and organs (Figure 5B). Outside particles within  
the nasal depth or best respiratory tract are caught in the bodily  
fluid, carried lower back to the throat, and gulped. From the  
diminish respiratory tract, foreign particles are brought up by  
way of the ciliary action of epithelial cells. Within the alveoli  
that need cilia or bodily fluid, macrophages are dependable for  
wrecking particles (Figure 5).  
5
Rapid Influenza Antigen (Nasal or Throat  
Swab)  
What is this test? This test rapidly checks for signs of the  
influenza viruses A and B in a sample of secretions from your  
nose or throat. Influenza or the "flu" is an illness of the  
respiratory system. Influenza A is further common than  
influenza B. It spreads effectively through water beads within  
the discuss from hacks or sniffles of individuals who are  
tainted. It regularly influences numerous individuals at the  
same time throughout fall and winter.  
Symptoms of the flu often show up suddenly. This is often  
about 1 to 4 days after you're tainted. Most individuals will get  
way better inside some days to less than 2 weeks. But those  
with a debilitated resistant framework may get serious  
pneumonia or other genuine issues. Your healthcare supplier  
can test for the flu in a few ways. This test as a rule gives comes  
about rapidly. Immunofluorescence is another test and  
employments a recoloring procedure. Comes about from these  
tests are not as precise as viral societies. But these tests are  
speedier and less demanding. They are commonly utilized for  
the primary screening. You do not continuously require a flu  
test for your supplier to analyze the flu. Healthcare suppliers  
may make the determination and start treatment based on your  
side effects and a physical exam.  
0
1ꢂ  
Journal of Environmental Treatment Techniques  
0202, Volume 8, Issue 2, Pages: 610-620  
Fig 5. Locales of the influenza section within the respiratory tract. (A) The anatomical and viable structures of the human aviation routes appear. Influenza,  
to begin with, contaminates the higher aviation route and the ciliated cells within the bronchus and bronchioli. Coming about logical disorders comprise  
of tracheitis, bronchitis, bronchiolitis, and bronchopneumonia. The versatile, safe reaction is started in lymph hubs nearby the aviation routes. (B) The  
respiratory epithelia are primarily outfitted to watch from approaching pathogens using a layer of bodily fluid (bronchus), ciliated cells (bronchus and  
bronchioli), and alveolar macrophages (alveoli) (42).  
acknowledgment of this perilous atom by cellular sensors,  
8
Histopathology  
which would something else trigger IFN α/β discharge (48-51).  
The flexible, safe response requires several days to be  
better than average, but at that point makes a distinction to  
contain the viral spread, to destroy the disease, and at final to  
set up a memory response coming approximately in a long-  
lived resistance to re-infection with the homologous disease.  
Cross-protection interior, a subtype of flu, has only scarcely  
ever been found, and contaminations truly set off no  
confirmation over subtypes or between sorts A and B (Treanor  
Influenza disease imitate within the epithelial phone lining  
of the beat and lower respiratory tracts. The pathology does no  
longer extend between home grew or test contamination.  
Conclusive conclusion of influenza serologic, immunologic,  
and atomic testing through RT-PCR for higher or lower  
respiratory tract examples. Mellow cases grandstand neurotic  
changes within the respiratory tracts; in any case, extreme  
occurrences exhibit explicit confirmation of pathologic  
alterations of pneumonia. The tracheobronchial changes due to  
influenza contamination can be summarized as redness and  
contamination with mucous and purulent discharge  
macroscopically, and desquamation and destruction of the  
pseudostratified epithelium of the trachea and bronchi with  
ultimately the basal layer remained viable however infected  
microscopically (44).  
2
005). Flu contamination activates each systemic and  
neighbourhood  
counteracting  
specialist  
(humoral  
insusceptibility), as fittingly as cytotoxic  
T
convenient  
responses (cellular insusceptibility), each of which is  
fundamental in patching from strongly debasement and  
resistance to reinfection (52, 53).  
1
0 Therapy  
9
Immunology  
Influenza causes intense contamination of the have and  
Right now, at slightest four antiviral capsules are helpful for  
the treatment and avoidance of flu. It is meriting of being  
mindful that in energizing immunocompetent people with  
intaglio resistance, there is a fast inconvenience within the  
capability of the flu infection; hence, the subterranean insect  
replication control of antiviral tablets is constrained and has no  
hypothetical impact. Too, no think about to date has confirmed  
a useful effect for antiviral retailers starting the past 48 hours of  
indication onset. The most prominent effect is classically  
viewed when cure is begun out within the, to begin with, 24  
hours. Treatment is embraced for each grown-up and kids with  
the flu infection defilement with the taking after criteria: 1)  
persons with laboratory-confirmed or distinctly suspected  
influenza virus contamination in high-risk corporations (table  
starts a cascade of safe responses enacting about all parts of the  
resistant defense framework. Most of the initial natural  
reaction, comprehensive of cytokine discharge (IFNα/β), influx  
of neutrophil granulocytes, or healthy executioner cells (45-  
4
7), and cell actuation, is dependable for the intense onset of  
the clinical indications (see over). Natural resistance is a  
fundamental prerequisite for the versatile resistant reaction,  
firstly, to constrain the starting viral replication and antigen  
stack, and since the antigen-specific lymphocytes of the  
versatile resistant reaction are enacted by co-stimulatory atoms  
that are initiated on cells of the intrinsic resistant framework  
amid their interaction with infections (Figure 6). Influenza  
diseases, in any case, encode inside the non-basic protein 1  
1
), inside 48 hours after symptom onset; 2) patients requiring  
(NS1) segments to keep away from and offend the IFN α/β  
hospitalization for laboratory-confirmed or outstandingly  
response. NS1 is likely to sequester viral dsRNA, which avoids  
0
1ꢃ  
Journal of Environmental Treatment Techniques  
0202, Volume 8, Issue 2, Pages: 610-620  
suspected flu infection, in any case of fundamental ailments, in  
case treatment can be started inside 48 hours after side effect  
onset; and 3) outpatients at high chance of issues (table 1) with  
a sickness that's not making strides and outpatients with high-  
quality flu take a see at conclusion result from an example  
gotten >48 hours after side effect onset. Individuals whose  
onset of signs is >48 hours sometime recently introduction with  
continuing moderate-to-severe illness.  
available antiviral drugs are changing quickly. Clinicians ought  
to be mindful of the nearby designs of flu circulations and  
susceptibilities. For occurrence, a meta-analysis appeared that  
NAIs were able to reduce mortality in patients conceded to the  
healing center with An H1N1pdm09 disease. Scattered  
oseltamivir-resistant contaminations have been recognized,  
along with different side scenes of restricted transmission (62).  
Given the as of now circulating flu A (H3N2) and 2009 H1N1  
infection resistance to adamantanes, these solutions are not  
suggested for utilizing against flu A virus-induced diseases. Be  
that as it may, most influenza A and B infection strains are still  
vulnerable to neuraminidases, for example, oseltamivir and  
zanamivir, with these drugs being chosen for treatment in  
demonstrated people (table 2). In expansion, it ought to be  
considered that the improvement of resistance to oseltamivir  
amid treatment was more common among regular flu A (H1N1)  
infection contaminations (27%) than among regular influenza  
A (H3N2) (3%) or B (0%) infection contaminations in a later  
ponder (63). Due to the confinements within the current  
restorative alternatives for the treatment of influenza.  
Amid the final widespread wave, neuraminidase inhibitors  
(NAIs)primarily oseltamivir and zanamivirwere broadly  
endorsed for patients with affirmed or suspected  
A
H1N1pdm09 infection (54-56). Be that as it may, sometimes  
newly the 200910 widespread, prove of their adequacy in  
regular flu, whereas reliable for unassuming indication  
diminishment, was less reliable for diminishes in pneumonia  
rate or pneumonia result change (57-60). Later information  
illustrated that patients with influenza-related pneumonia  
treated early after ailment onset) with an NAI experienced  
around one-third lower probability of biting the dust or  
requiring ventilator help compared to those treated at afterward  
hours (15, 61). Influenza viruses and their susceptibilities to  
Fig 6. Innate immunity is a necessary prerequisite for the versatile resistant reaction, firstly, to constrain the starting viral replication and antigen stack,  
and since the antigen-specific lymphocytes of the versatile resistant reaction are enacted by co-stimulatory atoms that are actuated on cells of the safe,  
natural framework amid their interaction with viruses.  
0
10  
Journal of Environmental Treatment Techniques  
0202, Volume 8, Issue 2, Pages: 610-620  
Table 1: Recommended dosages and durations of influenza antiviral medications for treatment or chemoprophylaxis  
Antiviral agent  
Oseltamivir  
Use  
Adults  
75 mg twice daily  
Treatment (5 d)  
Chemoprophylaxis (7 d)  
mg once 75  
daily  
Zanamivir  
Treatment (5 d)  
Chemoprophylaxis (7 d)  
10 mg (two 5-mg inhalations) twice daily  
10 mg (two 5-mg inhalations) once daily  
Virus infections, extra treatment choices with a diverse  
instrument of activity have been examined as a treatment for  
people with extreme influenza infection. For the case, a modest  
bunch of mAbs against influenza infection proteins are as of  
now within the early stages of assessment for human disease  
control (64). These mAbs target the external portions (i.e.,  
ectodomain) of the M2 protein (M2e). These mAbs target the  
outside parcels (i.e., ectodomain) of the M2 protein (M2e). The  
M2e is an alluring target for influenza immunizations and  
therapeutic antibodies since the significantly moderated nature  
of the corrosive amino groupings of its spaces among separates  
from diverse subtypes of influenza A viruses (65).  
too may be treated with antiviral drugs by their specialist  
this season. Most otherwise-healthy individuals who get  
flu, be that as it may, don't have to be be treated with  
antiviral drugs.  
1
3 Prevention  
3.1 Vaccination  
The first vital methodology for the anticipation of influenza  
1
and its serious results is yearly immunization against regular  
flu. The influenza infection is characterized by its high rate of  
transformation, beating the safe system’s work against unused  
variations (73), which is why novel vaccines are produced  
annually to match circulating viruses (74). The choice of  
influenza antigens to incorporate within the antibodies is based  
upon the worldwide reconnaissance of flu infections in  
circulation and the spread of available strains of the influenza  
disease around the world (75). For the subsequent influenza  
season within the southern side of the equator, proposals are  
made in September and for the influenza season within the  
northern side of the equator in February since around 6 to 8  
months are required to fabricate and approve novel  
immunizations. Recently, the World Wellbeing Organization  
The instruments of anti-M2e Abmediated assurance is not  
determined. Anti-M2 Abs do not have hemagglutination  
restraint capacity or in vitro infection neutralization properties  
(66). It is assumed that the most target for the hostile to- M2e  
counter acting agent is virus-infected human cells, which  
intensely express M2e on their surface (67). Most considers  
have detailed that corticosteroid treatment unfavorably impacts  
influenza-related results. Amid the 2009 flu widespread, 37%  
to 55% of the patients conceded to ICUs in Europe gotten  
corticosteroids as a portion of their treatment (68-70). In any  
case, in a later meta-analysis report, prove from observational  
studiesalbeit with essential limitations recommended that  
corticosteroid treatment for assumed influenza-associated  
complications was related to expanded mortality (71).  
(
WHO) suggested that trivalent influenza immunizations for  
utilize within the 2016 southern half of the globe flu season  
contain the taking after infection antigens(76):  
An A/California/7/2009 (H1N1) pdm09-like virus  
An A/Hong Kong/4801/2014  
(H3N2)-like virus  
1
1 Clinical trials with influenza antiviral drugs  
Most individuals with flu have gentle ailment and don't  
A B/Brisbane/60/2008-like virus  
The WHO stresses that vaccination is particularly vital for  
people at higher hazard of genuine flu complications, with  
the most noteworthy need managed to pregnant ladies—  
taken after by children matured between 6 and 59 months,  
elderly and people with particular unremitting restorative  
conditions (e.g., renal disappointment and diabetes  
mellitus), and at last people at tall chance (e.g., wellbeing  
staff) (77).  
require restorative care or antiviral drugs. On the off chance  
that you basically get weakened with flu side effects, in most  
cases, you have to be stay residential and keep up a key separate  
from contact with other individuals but to actuate restorative  
care. If, in any case, you have got side effects of flu and are in  
a high-risk bunch, or are exceptionally debilitated or stressed  
approximately your sickness, contact your wellbeing care  
supplier (specialist, doctor collaborator, etc.). CDC suggests  
provoke treatment for individuals who have flu contamination  
or suspected flu contamination and who are at tall hazard of  
genuine flu complications, such as individuals with asthma,  
diabetes or heart disease (72).  
In differentiate in 2010, the Joined together States’  
Counseling Committee on Immunization Hones (ACIP)  
expanded the proposal for yearly influenza immunization to  
include all people six months of age and more seasoned people  
who did not have contraindications without any need (78).  
1
2 You might need antiviral medication to treat  
1
3.2 Schedule  
flu:  
The episodes of flu, by and large, happen amid the final  
Antiviral drugs can treat flu illness  
harvest time and entirety winter months. A single dosage (0.5  
ccs) of an influenza antibody ought to be infused to grown-ups  
every year, ideally by October within the northern hemisphere  
and May within the southern half of the globe. Children  
matured between 6 months and eight a long time require two  
dosages of flu antibody (with at slightest four weeks separated)  
amid their first season of immunization for the typical reaction  
Antiviral drugs are different from antibiotics. Flu antivirals  
are prescription medicines (pills, liquid, intravenous  
solution, or an inhaled powder) and are not available over-  
the-counter  
Antiviral drugs can make ailment milder and abbreviate the  
time you're wiped out. They too can anticipate genuine flu  
complications, like pneumonia  
(
78).  
It’s very significant that antiviral drugs be used early to  
treat people who are very sick with flu (for instance, people  
who are in the hospital) and people who are wiped out with  
flu and have a more noteworthy chance of getting genuine  
flu complications, either since of their age or since they  
have a tall hazard therapeutic condition. Other individuals  
1
3.3 Efficacy  
The immunization adequacy of flu immunizations may be  
a determinant of how much the regular influenza vaccine can  
anticipate flu infection contaminations within the given  
populace amid an influenza season (79). As of late, the  
0
1ꢄ  
Journal of Environmental Treatment Techniques  
0202, Volume 8, Issue 2, Pages: 610-620  
documentation of the antigenic drift from the antibody weight  
in the lion's share of respected separates raised the subject that  
immunization viability may be problematic, primarily in more  
seasoned a long time or specific high-risk bunches. The Centers  
for Infection Control and Anticipation (CDC) within the Joined  
together the States of America had an estimation of 23% of  
immunization viability for the northern side of the equator  
chemoprophylaxis, and it's fitting utilize might too influence a  
markdown in dreariness, and mortality partnered to influenza  
in high-risk bunches (85).  
1
5 Conclusion  
We have considered how flu disease contamination leads to  
the noteworthy progression of a febrile respiratory affliction.  
The pathogenesis is characterized by way of the convenient  
replication and scattering of the disease insides the lungs,  
causing neighborhood and systemic defilement and cytokine  
release. These events, collectively with the flexible safe  
response, offer help to decrease the viral burden, to encourage  
liberated of the disease, and to set off clutter recovery. The  
humoral and cellular resistant reactions, incited by way of  
disease or inoculation, outfit people and populaces with long-  
lasting cautious insusceptibility in resistance to related viral  
strains. Influenza, be that as it may, can weaken this  
contamination- or vaccine-derived insusceptibility through  
implies of antigenic move and float, coming about in plague  
and widespread flare-ups. Specialized advancements, alongside  
hereditary and down to earth ponders, will help to realize a  
further profound discernment into the pathogenesis of  
antiquated and directly circulating virulent influenza strains.  
This understanding and a far reaching acknowledgment  
roughly the viral safe security disobedient inside the human  
lung will ideally energize the headway of prevalent treatment  
choices and more unmistakable high-quality immunizations to  
be allocated around the world against current and future flu  
disease varieties.  
2
01415 regular flu antibody due to a jumble within the  
circulating infections and antibody contained infections (80).  
What ought to be taken into thought is that indeed if an  
antibody is not wholly related to the overwhelming circulating  
infection, it can watch various particular flu infections and can,  
as such, bestow exact assurance and stop influenza-related  
sicknesses. It is additionally a reality that flu immunizations are  
secured and are particularly imperative for diminishing severe  
illness in a few high-risk populaces. In like manner, the WHO  
suggests regular flu antibodies indeed on the off chance that  
they are not carefully related to the overwhelming circulating  
flu infections each year for the organizations mentioned above  
(24).  
1
4 Chemoprophylaxis Strategy  
Accessible antiviral drugs play a vital part in patients who  
have not been immunized or who are nonresponsive to  
antibodies. Oseltamivir and zanamivir are the prescribed drugs  
for the avoidance of influenza based on their built up adequacy  
and moo rates of resistance in comparison to adamantanes (81,  
8
2). These operators are successful for the anticipation of  
influenza in reliable people, people at high hazard of flu  
complications, and those dwelling in long-term care offices.  
The adequacy of oseltamivir and zanamivir has, however, to be  
compared with each other (83). It ought to be emphasized that  
when choosing a technique of antiviral chemoprophylaxis, a  
few parameters such as anticipating complications in patients  
at high hazard and lessening the chance of advancing sedate  
antiviral resistance ought to be considered. There are, hence, a  
few signs for this approach, as follows (84): 1) Influenza  
prophylaxis amid influenza episodes in long-term care centers  
within the elderly notwithstanding earlier influenza  
vaccinations. 2) In unvaccinated people at the high chance of  
influenza complications which have been uncovered to a  
person with influenza diseases inside the past 48 hours. 3)  
Antiviral prophylaxis for immunized people at the high chance  
of influenza complications who have had near contact with a  
person with influenza inside the previous 48 hours when there  
is a destitute coordinate between the immunization and  
circulating infections in a given year. 4) The Joined together  
States’ ACIP suggests that antiviral chemoprophylaxis be  
considered in pregnant women and in women up to 2 weeks  
postpartum who have close contact with suspected or  
confirmed influenza A-infected individuals. Zanamivir may be  
the drug of choice for prophylaxis due to its limited systemic  
absorption (84, 85).  
Medicate resistance got to be respected on the off chance  
that we select to bargain with all sufferers who are labeled as  
battling from influenza. People with suspected pipe with an  
extraordinary affliction such as those with side effects and signs  
of diminishing respiratory tract contaminations (e.g., dyspnea,  
tachypnea, and moo oxygen immersion) and these who have  
side effects of quick clinical deterioration or these at great  
danger of issues got to get hold of antiviral treatment. In all  
cases, antivirals ought to be started <48 hours after side effect  
onset. In pregnant patients due to more noteworthy mortality,  
there is a counsel that all sufferers with suspected or affirmed  
influenza-even those who were existing >48 hours after side  
effect onsetbe managed with provided that they are not  
making strides. In expansion, an unused appear at antiviral  
References  
1. Alguacil-Ramos A, Portero-Alonso A, Pastor-Villalba E, Muelas-  
Tirado J, Díez-Domingo J, Sanchis-Ferrer A, et al. Rapid  
assessment of enhanced safety surveillance for influenza vaccine.  
Public health. 2019;168:137-41.  
2
.
Tennant RK, Holzer B, Love J, Tchilian E, White HN. Higher  
levels of B‐cell mutation in the early germinal centres of an  
inefficient secondary antibody response to a variant influenza  
haemagglutinin. Immunology. 2019;157(1):86-91.  
3
.
Marshall C, Williams K, Matchett E, Hobbs L. Sustained  
improvement in staff influenza vaccination rates over six years  
without a mandatory policy. Infection Control & Hospital  
Epidemiology. 2019;40(3):389-90.  
4
5
.
.
Mousavi S, Zarei M, Hashemi S. Polydopamine for Biomedical  
Application and Drug Delivery System. Med Chem(Los Angeles).  
2
018;8:218-29.  
Mosnier A, Caini S, Daviaud I, Nauleau E, Bui TT, Debost E, et  
al. Clinical characteristics are similar across type A and B  
influenza virus infections. PLoS One. 2015;10(9):e0136186.  
6. Poon LL, Song T, Rosenfeld R, Lin X, Rogers MB, Zhou B, et al.  
Quantifying influenza virus diversity and transmission in humans.  
Nature genetics. 2016;48(2):195.  
7
.
Fuller TL, Gilbert M, Martin V, Cappelle J, Hosseini P, Njabo KY,  
et al. Predicting hotspots for influenza virus reassortment.  
Emerging infectious diseases. 2013;19(4):581.  
8
.
Mousavi SM, Hashemi SA, Ghasemi Y, Amani AM, Babapoor A,  
Arjmand O. Applications of graphene oxide in case of  
nanomedicines and nanocarriers for biomolecules: review study.  
Drug metabolism reviews. 2019;51(1):12-41.  
9. Mousavi SM, Hashemi SA, Ghasemi Y, Atapour A, Amani AM,  
Savar Dashtaki A, et al. Green synthesis of silver nanoparticles  
toward bio and medical applications: review study. Artificial cells,  
nanomedicine, and biotechnology. 2018;46(sup3):S855-S72.  
1
0. Mousavi S, Hashemi S, Zarei M, Amani A, Babapoor A.  
Nanosensors for Chemical and Biological and Medical  
Applications. Med Chem (Los Angeles). 2018;8(8):2161-  
0
444.1000515.  
11. Kanegae Y, Sugita S, Endo A, Ishida M, Senya S, Osako K, et al.  
Evolutionary pattern of the hemagglutinin gene of influenza B  
viruses isolated in Japan: cocirculating lineages in the same  
epidemic season. Journal of virology. 1990;64(6):2860-5.  
0
1ꢅ  
Journal of Environmental Treatment Techniques  
0202, Volume 8, Issue 2, Pages: 610-620  
1
1
2. Boivin G, Goyette N, Bernatchez H. Prolonged excretion of  
amantadine-resistant influenza a virus quasi species after cessation  
of antiviral therapy in an immunocompromised patient. Clinical  
Infectious Diseases. 2002;34(5):e23-e5.  
3. Степанова ЛА, Ковалева А, Потапчук М, Коротков А,  
Куприянов В, Блохина Е, et al. Иммуногенные свойства  
рекомбинантных белков, включающих эктодомен белка М2  
вируса гриппа а. Вопросы вирусологии. 2013;58(3).  
Prevention. Hospitalized patients with novel influenza A (H1N1)  
virus infection--California. 2009:732-6.  
34. Chu H, Lofgren ET, Halloran ME, Kuan PF, Hudgens M, Cole SR.  
Performance of rapid influenza H1N1 diagnostic tests: a meta‐  
analysis. Influenza and other respiratory viruses. 2012;6(2):80-6.  
35. Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy  
of rapid influenza diagnostic tests: a meta-analysis. Annals of  
internal medicine. 2012;156(7):500-11.  
1
1
4. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M.  
Transmission of influenza A in human beings. The Lancet  
infectious diseases. 2007;7(4):257-65.  
5. Mousavi SM, Hashemi SA, Zarei M, Bahrani S, Savardashtaki A,  
Esmaeili H, et al. Data on cytotoxic and antibacterial activity of  
synthesized Fe3O4 nanoparticles using Malva sylvestris. Data in  
brief. 2020;28:104929.  
36. Karthik L, Kumar G, Keswani T, Bhattacharyya A, Chandar SS,  
Rao KB. Protease inhibitors from marine actinobacteria as a  
potential source for antimalarial compound. PloS one. 2014;9(3).  
37. Nagase H, Moriwaki K, Kamae M, Yanagisawa S, Kamae I. Cost-  
effectiveness analysis of oseltamivir for influenza treatment  
considering the virus emerging resistant to the drug in Japan. Value  
in Health. 2009;12:S62-S5.  
1
6. Choi W-S, Lee J, Lee H-Y, Baek J-H, Kim Y-K, Kee S-Y, et al.  
Clinical Practice Guideline for Antiviral Treatment and  
38. Nshimyumukiza L, Douville X, Fournier D, Duplantie J, Daher  
RK, Charlebois I, et al. Cost‐effectiveness analysis of antiviral  
treatment in the management of seasonal influenza A: point‐of‐  
care rapid test versus clinical judgment. Influenza and other  
respiratory viruses. 2016;10(2):113-21.  
Chemoprophylaxis of Seasonal Influenza. Infection  
Chemotherapy. 2012;44(4).  
&
1
1
1
7. Cowling BJ, Ip DK, Fang VJ, Suntarattiwong P, Olsen SJ, Levy J,  
et al. Aerosol transmission is an important mode of influenza A  
virus spread. Nature communications. 2013;4:1935.  
8. Wong BC, Lee N, Li Y, Chan PK, Qiu H, Luo Z, et al. Possible  
role of aerosol transmission in a hospital outbreak of influenza.  
Clinical infectious diseases. 2010;51(10):1176-83.  
9. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S,  
Leach S, et al. Time lines of infection and disease in human  
influenza: a review of volunteer challenge studies. American  
journal of epidemiology. 2008;167(7):775-85.  
0. Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of  
multidrug-resistant influenza A virus in an immunocompromised  
patient. New England Journal of Medicine. 2003;348(9):867-8.  
1. Liu W, Peng L, Liu H, Hua S. Pulmonary function and clinical  
manifestations of patients infected with mild influenza A virus  
subtype H1N1: a one-year follow-up. PloS one. 2015;10(7).  
2. Rello J, Pop-Vicas A. Clinical review: primary influenza viral  
pneumonia. Critical Care. 2009;13(6):235.  
39. Klugman K. Clinical Microbiology Reviews. Clin Microbiol Rev.  
1990;3(2):171-96.  
40. Teo J, Di Pietro P, San Biagio F, Capozzoli M, Deng Y-M, Barr I,  
et al. VereFlu™: an integrated multiplex RT-PCR and microarray  
assay for rapid detection and identification of human influenza A  
and B viruses using lab-on-chip technology. Archives of virology.  
2011;156(8):1371.  
41. Tang Y-W, Lowery KS, Valsamakis A, Schaefer VC, Chappell JD,  
White-Abell J, et al. Clinical accuracy of a PLEX-ID flu device for  
simultaneous detection and identification of influenza viruses A  
and B. Journal of clinical microbiology. 2013;51(1):40-5.  
42. Loeffelholz M, Pong D, Pyles R, Xiong Y, Miller A, Bufton K, et  
al. Comparison of the FilmArray Respiratory Panel and Prodesse  
real-time PCR assays for detection of respiratory pathogens.  
Journal of clinical microbiology. 2011;49(12):4083-8.  
43. Gholami A, Shahin S, Mohkam M, Nezafat N, Ghasemi Y.  
Cloning, characterization and bioinformatics analysis of novel  
cytosine deaminase from Escherichia coli AGH09. International  
Journal of Peptide Research and Therapeutics. 2015;21(3):365-74.  
44. Moghadami M. A narrative review of influenza: a seasonal and  
pandemic disease. Iranian journal of medical sciences.  
2017;42(1):2.  
2
2
2
2
3. Minodier L, Charrel RN, Ceccaldi P-E, Van Der Werf S, Blanchon  
T, Hanslik T, et al. Prevalence of gastrointestinal symptoms in  
patients with influenza, clinical significance, and pathophysiology  
of human influenza viruses in faecal samples: what do we know?  
Virology journal. 2015;12(1):215.  
2
2
4. Vickers NJ. Animal Communication: When I’m Calling You, Will  
You Answer Too? Current Biology. 2017;27(14):R713-R5.  
5. Mancinelli L, Onori M, Concato C, Sorge R, Chiavelli S, Coltella  
L, et al. Clinical features of children hospitalized with influenza A  
and B infections during the 20122013 influenza season in Italy.  
BMC infectious diseases. 2015;16(1):6.  
6. Bahrani S, Hashemi SA, Mousavi SM, Azhdari R. Zinc-based  
metalorganic frameworks as nontoxic and biodegradable  
platforms for biomedical applications: review study. Drug  
metabolism reviews. 2019;51(3):356-77.  
7. Rello J, Rodríguez A, Ibañez P, Socias L, Cebrian J, Marques A,  
et al. the H1N1 SEMICYUC working group: Intensive care  
patients with severe novel H1N1 influenza viral pneumonia in  
Spain. Crit Care. 2009;13:R148.  
8. To K, Hung I, Li I, Lee K, Koo C, Yan W, et al. Pandemic H1N1  
Study Group: Delayed clearance of viral load and marked cytokine  
activation in severe cases of pandemic H1N1 2009 influenza virus  
infection. Clin Infect Dis. 2010;50:850-9.  
45. Behrens G, Stoll M, Kamps B, Hoffman C, Preisser W.  
Pathogenesis and immunology. Monografía en Internet] Flying  
Publisher Cologne, Holland. 2006;19.  
46. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin  
Y, et al. Recognition of haemagglutinins on virus-infected cells by  
NKp46 activates lysis by human NK cells. Nature.  
2001;409(6823):1055-60.  
47. Mousavi SM, Zarei M, Hashemi SA, Babapoor A, Amani AM. A  
conceptual review of rhodanine: current applications of antiviral  
drugs, anticancer and antimicrobial activities. Artificial cells,  
nanomedicine, and biotechnology. 2019;47(1):1132-48.  
48. García-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE,  
Durbin JE, et al. Influenza A virus lacking the NS1 gene replicates  
in interferon-deficient systems. Virology. 1998;252(2):324-30.  
49. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solórzano A,  
Swayne DE, et al. Characterization of the reconstructed 1918  
Spanish influenza pandemic virus. science. 2005;310(5745):77-80.  
50. Abbaszadegan A, Dadolahi S, Gholami A, Moein MR, Hamedani  
S, Ghasemi Y, et al. Antimicrobial and cytotoxic activity of  
Cinnamomum zeylanicum, Calcium Hydroxide, and triple  
antibiotic paste as root canal dressing materials. The journal of  
contemporary dental practice. 2016;17(2):105-13.  
51. Gholami A, Rasoul-Amini S, Ebrahiminezhad A, Abootalebi N,  
Niroumand U, Ebrahimi N, et al. Magnetic properties and  
antimicrobial effect of amino and lipoamino acid coated iron oxide  
nanoparticles. Minerva Biotecnologica. 2016;28(4):177-86.  
52. Mousavi SM, Soroshnia S, Hashemi SA, Babapoor A, Ghasemi Y,  
Savardashtaki A, et al. Graphene nano-ribbon based high potential  
and efficiency for DNA, cancer therapy and drug delivery  
applications. Drug metabolism reviews. 2019;51(1):91-104.  
53. Abbaszadegan A, Gholami A, Abbaszadegan S, Aleyasin ZS,  
Ghahramani Y, Dorostkar S, et al. The effects of different ionic  
liquid coatings and the length of alkyl chain on antimicrobial and  
2
2
2
2
3
3
9. Schwarzmann SW, Adler JL, Sullivan RJ, Marine WM. Bacterial  
pneumonia during the Hong Kong influenza epidemic of 1968-  
1
969: experience in a city-county hospital. Archives of internal  
medicine. 1971;127(6):1037-41.  
0. Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, Fosheim  
G, et al. Staphylococcus aureus community-acquired pneumonia  
during the 2006 to 2007 influenza season. Annals of emergency  
medicine. 2009;53(3):358-65.  
1. Ison MG, Campbell V, Rembold C, Dent J, Hayden FG. Cardiac  
findings during uncomplicated acute influenza in ambulatory  
adults. Clinical infectious diseases. 2005;40(3):415-22.  
2. Foulkes W, Rees J, Sewry C. Influenza A and rhabdomyolysis.  
Journal of Infection. 1990;21(3):303-4.  
3
3
3. Chen K-F, Gaydos C, Rothman RE. Update on emerging  
infections: news from the Centers for Disease Control and  
0
1ꢆ  
Journal of Environmental Treatment Techniques  
0202, Volume 8, Issue 2, Pages: 610-620  
cytotoxic properties of silver nanoparticles. Iranian endodontic  
journal. 2017;12(4):481.  
systematic review and meta-analysis. The Journal of infectious  
diseases. 2015;212(2):183-94.  
5
5
4. Muthuri Stella G, Sudhir V, Myles Puja R, Jo L-B, Al Khuwaitir  
Tarig S. Effectiveness of neuraminidase inhibitors in reducing  
mortality in patients admitted to hospital with influenza A  
72. Zakeri A, Kouhbanani MAJ, Beheshtkhoo N, Beigi V, Mousavi  
SM, Hashemi SAR, et al. Polyethylenimine-based nanocarriers in  
co-delivery of drug and gene: a developing horizon. Nano reviews  
& experiments. 2018;9(1):1488497.  
73. Kilbourne ED. Influenza immunity: new insights from old studies.  
The Journal of infectious diseases. 2006;193(1):7-8.  
H1N1pdm09 virus infection:  
a meta-analysis of individual  
participant data. Lancet Respir Med. 2014;2(5):395-404.  
5. Gasparini R, Amicizia D, Lai PL, Bragazzi NL, Panatto D.  
Compounds with anti-influenza activity: present and future of  
strategies for the optimal treatment and management of influenza  
Part II: Future compounds against influenza virus. Journal of  
preventive medicine and hygiene. 2014;55(4):109.  
6. Mousavi SM, Hashemi SA, Salahi S, Hosseini M, Amani AM,  
Babapoor A. Development of Clay Nanoparticles Toward Bio and  
Medical Applications. Current Topics in the Utilization of Clay in  
Industrial and Medical Applications. 2018;9:167.  
7. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact  
of oseltamivir treatment on influenza-related lower respiratory  
tract complications and hospitalizations. Archives of internal  
medicine. 2003;163(14):1667-72.  
8. Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, et  
al. Antivirals for treatment of influenza: a systematic review and  
meta-analysis of observational studies. Annals of internal  
medicine. 2012;156(7):512-24.  
74. Glezen WP. Prevention and treatment of seasonal influenza. New  
England Journal of Medicine. 2008;359(24):2579-85.  
75. Ang LW, Tien WS, Lin RTP, Cui L, Cutter J, James L, et al.  
Characterization of influenza activity based on virological  
surveillance of influenza‐like illness in tropical Singapore, 2010–  
2014. Journal of medical virology. 2016;88(12):2069-77.  
76. Zhao B, Qin S, Teng Z, Chen J, Yu X, Gao Y, et al.  
Epidemiological study of influenza B in Shanghai during the  
20092014 seasons: implications for influenza vaccination  
strategy. Clinical Microbiology and Infection. 2015;21(7):694-  
700.  
77. Kalkowska DA, Tebbens RJD, Pallansch MA, Cochi SL, Wassilak  
SG, Thompson KM. Modeling undetected live poliovirus  
circulation after apparent interruption of transmission:  
implications for surveillance and vaccination. BMC infectious  
diseases. 2015;15(1):66.  
5
5
5
5
6
9. Doshi P, Jefferson T, Del Mar C. The imperative to share clinical  
study reports: recommendations from the Tamiflu experience.  
PLoS medicine. 2012;9(4).  
0. Atapour A, Negahdaripour M, Ghasemi Y, Razmjuee D,  
Savardashtaki A, Mousavi SM, et al. In Silico Designing a  
Candidate Vaccine Against Breast Cancer. International Journal of  
Peptide Research and Therapeutics. 2019:1-12.  
78. Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA,  
Petrie JG, et al. 20142015 influenza vaccine effectiveness in the  
United States by vaccine type. Clinical Infectious Diseases.  
2016:ciw635.  
79. Ohmit SE, Petrie JG, Malosh RE, Fry AM, Thompson MG, Monto  
AS. Influenza vaccine effectiveness in households with children  
during the 20122013 season: assessments of prior vaccination and  
serologic susceptibility. The Journal of infectious diseases.  
2015;211(10):1519-28.  
80. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson  
ML, Jackson LA, et al. Early estimates of seasonal influenza  
vaccine effectivenessUnited States, January 2015. MMWR  
Morbidity and mortality weekly report. 2015;64(1):10.  
81. Li T, Chan MC, Lee N. Clinical implications of antiviral resistance  
in influenza. Viruses. 2015;7(9):4929-44.  
82. Avval ZM, Malekpour L, Raeisi F, Babapoor A, Mousavi SM,  
Hashemi SA, et al. Introduction of magnetic and supermagnetic  
nanoparticles in new approach of targeting drug delivery and  
cancer therapy application. Drug Metabolism Reviews. 2019:1-28.  
83. Merritt T, Hope K, Butler M, Durrheim D, Gupta L, Najjar Z, et  
al. Effect of antiviral prophylaxis on influenza outbreaks in aged  
care facilities in three local health districts in New South Wales,  
Australia, 2014. Western Pacific surveillance and response  
journal: WPSAR. 2016;7(1):14.  
6
6
1. Khandaker G, Al Mamun A, Anovadiya AP, Araujo W, Azziz-  
Baumgartner E. Impact of neuraminidase inhibitors on influenza A  
(H1N1) pdm09-related pneumonia: an individual participant data  
meta-analysis. 2016.  
2. Chen LF, Dailey NJ, Rao AK, Fleischauer AT, Greenwald I,  
Deyde VM, et al. Cluster of oseltamivir-resistant 2009 pandemic  
influenza A (H1N1) virus infections on a hospital ward among  
immunocompromised patientsNorth Carolina, 2009. Journal of  
Infectious Diseases. 2011;203(6):838-46.  
3. Stephenson I, Democratis J, Lackenby A, McNally T, Smith J,  
Pareek M, et al. Neuraminidase inhibitor resistance after  
oseltamivir treatment of acute influenza A and B in children.  
Clinical Infectious Diseases. 2009;48(4):389-96.  
4. Ramos EL, Mitcham JL, Koller TD, Bonavia A, Usner DW,  
Balaratnam G, et al. Efficacy and safety of treatment with an anti-  
m2e monoclonal antibody in experimental human influenza. The  
Journal of infectious diseases. 2015;211(7):1038-44.  
6
6
6
6
5. Schotsaert M, De Filette M, Fiers W, Saelens X. Universal M2  
ectodomain-based influenza A vaccines: preclinical and clinical  
developments. Expert review of vaccines. 2009;8(4):499-508.  
6. Jegerlehner A, Schmitz N, Storni T, Bachmann MF. Influenza A  
vaccine based on the extracellular domain of M2: weak protection  
mediated via antibody-dependent NK cell activity. The Journal of  
Immunology. 2004;172(9):5598-605.  
7. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw  
F-M, Lim WS, et al. The effectiveness of convalescent plasma and  
hyperimmune immunoglobulin for the treatment of severe acute  
respiratory infections of viral etiology: a systematic review and  
exploratory meta-analysis. The Journal of infectious diseases.  
84. Louie JK, Salibay CJ, Kang M, Glenn-Finer RE, Murray EL,  
Jamieson DJ. Pregnancy and severe influenza infection in the  
20132014 influenza season. Obstetrics  
&
Gynecology.  
2015;125(1):184-92.  
85. Tech JET. Investigating the Activity of Antioxidants Activities  
Content in Apiaceae and to Study Antimicrobial and Insecticidal  
Activity of Antioxidant by using SPME Fiber Assembly  
Carboxen/Polydimethylsiloxane (CAR/PDMS). Journal of  
Environmental Treatment Techniques. 2020;8(1):214-24.  
6
2
015;211(1):80-90.  
6
6
7
7
8. Diaz E, Martin-Loeches I, Canadell L, Vidaur L, Suarez D, Socias  
L, et al. Corticosteroid therapy in patients with primary viral  
pneumonia due to pandemic (H1N1) 2009 influenza. Journal of  
Infection. 2012;64(3):311-8.  
9. Brun-Buisson C, Richard J-CM, Mercat A, Thiébaut AC, Brochard  
L. Early corticosteroids in severe influenza A/H1N1 pneumonia  
and acute respiratory distress syndrome. American journal of  
respiratory and critical care medicine. 2011;183(9):1200-6.  
0. Linko R, Pettilä V, Ruokonen E, Varpula T, Karlsson S, Tenhunen  
J, et al. Corticosteroid therapy in intensive care unit patients with  
PCR‐confirmed influenza A (H 1 N 1) infection in F inland. Acta  
anaesthesiologica scandinavica. 2011;55(8):971-9.  
1. Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam JS, Lim WS. Effect  
of corticosteroid therapy on influenza-related mortality:  
a
0
ꢀ6